AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Thermo Fisher Scientific Inc. Ranks 69th in Trading Volume with $10.82 Billion as mRNA Partnership Boosts Growth Prospects
Generated by AI AgentAinvest Volume Radar
Friday, Jun 27, 2025 7:55 pm ET1min read
On June 27, 2025,
(TMO) closed at $598.12, with a trading volume of $10.82 billion, ranking 69th in the day's stock market. The stock price decreased by 0.92%.Thermo Fisher Scientific Inc. has announced a strategic partnership with Ethris GmbH to integrate mRNA technology into its existing product portfolio. This collaboration aims to enhance the company's capabilities in the field of mRNA therapeutics, which are expected to play a crucial role in the development of new treatments for various diseases.
In addition to the partnership with Ethris,
has also been focusing on expanding its presence in the biotechnology sector. The company has been investing in research and development to bring innovative solutions to the market, which has been well-received by investors and analysts alike.Thermo Fisher's commitment to innovation and strategic partnerships is expected to drive growth in the coming quarters. The company's strong financial performance and robust pipeline of new products are likely to continue attracting investors, despite the recent market volatility.
Ainvest Volume Radar
Hunt down the stocks with explosive trading volume.
Latest Articles
Kraft Heinz Slides 1.02% as Stock Ranks 486th in Daily Trading Volume Amid Institutional Splits Earnings Woes and Dividend Strain Weigh on Investor Confidence
Dec.05 2025
AVAV's 3.15% Slide Amid 21% Volume Drop, 475th Rank Signal Earnings Optimism Fizzles
Dec.05 2025
Align Technology Extends Three-Day Rally with 0.24 Gain Ranks 452nd in $250M Turnover as Dental Sector Outperforms Peers
Dec.05 2025
PPG's 0.36% Rise Outpaces 448th-Ranked Volume as Analysts Boost Aerospace Growth Outlook
Dec.05 2025
Akamai's FedRAMP Certification Drives 31.33% Volume Surge to 445th Rank, but Stock Dips 3.59% on Investor Caution
Dec.05 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet